Recombinant Rupicapra rupicapra Kappa-casein (CSN3)

Shipped with Ice Packs
In Stock

Description

Protein Overview and Function

Kappa-casein (CSN3) is a critical component of casein micelles in milk, stabilizing their structure and influencing milk-clotting properties during cheese production . The mature protein contains 169 amino acids (after a 21-residue signal peptide) and includes hydrophobic (N-terminal) and hydrophilic (C-terminal) regions . Its C-terminal region is glycosylated, which enhances micelle stability .

  • The CSN3 gene spans ~14 kb, with exon 4 encoding most of the mature protein .

  • Polymorphisms in exon 4 (e.g., silent or nonsynonymous variants) can alter milk yield and composition .

Recombinant Production

Recombinant CSN3 is typically produced via prokaryotic systems (e.g., E. coli) due to their scalability and cost-effectiveness . Key production parameters include:

ParameterBovine CSN3 Goat CSN3
Host organismE. coliE. coli/yeast
Expression regionAA 22–190Full-length mature
Purification tagsHis/GSTHis/Myc
Purity>90%>85%
Molecular weight~50 kDa~21–26 kDa

While no data exists for Rupicapra rupicapra, these production metrics suggest similar approaches would apply, with host selection depending on desired post-translational modifications (e.g., glycosylation in yeast systems).

Applications in Research

Recombinant CSN3 is used in:

  • Western blotting and SDS-PAGE for protein expression validation .

  • Milk coagulation studies to mimic natural casein micelle destabilization .

  • Nutritional research, as CSN3-derived peptides exhibit antimicrobial and immunomodulatory effects .

A 2022 review highlighted CSN3’s role in oral health and infant nutrition, though these findings were based on human and bovine models . For Rupicapra rupicapra, such studies would require species-specific recombinant variants.

Research Gaps and Future Directions

No studies directly address Rupicapra rupicapra CSN3, limiting its characterization. Prioritized research areas include:

  1. Gene sequencing to identify polymorphisms in exon 4.

  2. Functional assays to link CSN3 variants with milk-clotting efficiency.

  3. In silico modeling to predict structural changes from sequence data .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies based on purchasing method and location. Please consult local distributors for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize developing it.
Synonyms
CSN3; CSN10; CSNK; Kappa-casein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
22-192
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Rupicapra rupicapra (Chamois)
Target Names
CSN3
Target Protein Sequence
QEQNQEQSI CCEKDERFFE DKIAKYIPIQ YVLSRYPSYG LNYYQQRPVA LINNQFLPYP YYAKPVAVRS PAQTLQWQVL PNTAPAKSCQ DQPTTMAHHP HPHLSFMAIP PKKDQDKTEI PTINTIASAE PTVHSTPTTE AIVNTVDNPE ASSESIASAP ETNTAQVTST EV
Uniprot No.

Target Background

Function
Kappa-casein stabilizes micelle formation, preventing casein precipitation in milk.
Protein Families
Kappa-casein family
Subcellular Location
Secreted.
Tissue Specificity
Mammary gland specific. Secreted in milk.

Q&A

What are the key genetic characteristics of Rupicapra rupicapra Kappa-casein promoter regions?

Based on comparative analysis with bovine models, Rupicapra rupicapra Kappa-casein likely contains promoter regions with significant regulatory elements. In bovine studies, two distinct haplotypes (A and B) have been identified in the kappa-casein gene promoter, differing at positions -514 (T/G), -426 (T/C), and -384 (T/C) . For Rupicapra rupicapra, researchers should examine these analogous regions for species-specific regulatory elements through detailed genomic analysis. Particular attention should be paid to putative transcription factor binding sites, as these are critical for expression regulation. When analyzing promoter regions, employ both sequencing and functional analysis to verify regulatory activity.

How do Rupicapra rupicapra CSN3 polymorphisms compare to those in other ruminant species?

While detailed polymorphism data for Rupicapra rupicapra is still emerging, comparative analysis with other ruminants provides valuable insights. Bovine kappa-casein studies show that the A allele is dominant in dairy breeds (frequency of 88.9%), while being less prevalent in beef animals (75%) . When studying Rupicapra rupicapra, researchers should sequence multiple individuals from diverse populations to establish allele frequencies and identify unique polymorphisms. A thorough methodology includes:

  • DNA extraction from multiple samples across different geographic regions

  • PCR amplification of the CSN3 gene and promoter regions

  • Sequencing and alignment analysis

  • Haplotype identification and frequency calculation

  • Comparative analysis with published ruminant data

What expression systems are most suitable for producing functional recombinant Rupicapra rupicapra Kappa-casein?

  • Codon optimization for the host organism

  • Inclusion of appropriate secretion signals if targeting secreted expression

  • Selection of fusion tags to aid solubility and purification (His and GST tags have proven effective for bovine kappa-casein)

  • Evaluation of glycosylation requirements for functional studies

What experimental design approaches maximize recombinant Rupicapra rupicapra Kappa-casein expression?

Implementing robust experimental design is crucial for optimizing recombinant protein expression. A factorial design approach allows researchers to systematically evaluate multiple variables simultaneously, identifying significant effects while minimizing experimental runs . For Rupicapra rupicapra Kappa-casein expression, consider these critical design principles:

  • Ensure experiments are unbiased with true comparisons between treatment groups

  • Maximize precision through uniform materials and randomized block designs

  • Explore sensitivity to variables including strain, media composition, and induction conditions

  • Keep designs simple to prevent experimental errors

  • Design experiments to enable statistical analysis for quantifying confidence levels

A multivariate approach is particularly effective, allowing evaluation of interactions between variables rather than the limited insights from univariate methods . For expression optimization, implement a fractional factorial design (2^n-k) to efficiently screen variables including temperature, inducer concentration, media composition, and induction timing.

How should researchers optimize culture conditions for soluble expression of Rupicapra rupicapra Kappa-casein?

Soluble expression of recombinant proteins remains challenging, requiring systematic optimization. For Rupicapra rupicapra Kappa-casein, focus on these key variables:

VariableRecommended RangeImpact on Soluble Expression
Temperature16-30°CLower temperatures (16-25°C) often increase solubility
Inducer concentration0.1-1.0 mM IPTGLower concentrations may favor soluble expression
Induction timingOD600 0.6-1.0Mid-log phase generally optimal
Media compositionLB, TB, or defined mediaRicher media supports higher biomass but may increase inclusion body formation
Post-induction time4-6 hoursShorter times may prevent aggregation

Implement a statistical experimental design to identify optimal combinations of these variables. Studies with other recombinant proteins have demonstrated that induction times between 4-6 hours provide the highest productivity levels while minimizing aggregation and proteolytic degradation .

What analytical methods are most effective for characterizing recombinant Rupicapra rupicapra Kappa-casein?

Comprehensive characterization requires multiple complementary techniques:

  • Molecular weight determination: SDS-PAGE and mass spectrometry. Bovine recombinant kappa-casein shows a predicted mass of 49 kDa with His and GST tags , though native size varies by species.

  • Verification of identity: N-terminal sequencing confirms authenticity, as demonstrated with recombinant human CMP .

  • Purity assessment: HPLC analysis, with >90% purity achievable through sequential purification steps .

  • Post-translational modification analysis: Specialized glycoprotein staining methods and mass spectrometry for glycosylation patterns, which differ between recombinant and native proteins .

  • Functional characterization: Species-specific functional assays based on kappa-casein's biological roles.

What purification strategy yields the highest recovery of functional Rupicapra rupicapra Kappa-casein?

Based on analogous protein purification studies, a multi-step approach is recommended:

  • Initial separation: For secreted expression, begin with molecular cut-off ultrafiltration to concentrate the protein and remove small molecular weight contaminants .

  • Affinity chromatography: If expressing with affinity tags (His or GST), employ immobilized metal affinity chromatography or glutathione affinity chromatography as the primary capture step .

  • Ion exchange chromatography: Anion exchange chromatography has proven effective for CMP purification, exploiting the acidic properties of kappa-casein (predicted isoelectric point around 5.9 for bovine kappa-casein) .

  • Polishing step: Size exclusion chromatography to remove aggregates and achieve final purity >94% .

For non-tagged proteins, exploit kappa-casein's unique properties, particularly its solubility at pH 4.6 where other caseins precipitate.

How can researchers assess and maintain the stability of purified recombinant Rupicapra rupicapra Kappa-casein?

Stability assessment requires systematic evaluation:

  • Thermal stability testing: Conduct accelerated degradation tests (e.g., 37°C incubation for 48h) to evaluate thermal stability and establish appropriate storage conditions .

  • Storage optimization: For short-term storage (≤1 month), maintain at 2-8°C; for long-term storage, aliquot and store at -80°C to prevent freeze-thaw cycle damage .

  • Buffer formulation: PBS (pH 7.4) with stabilizing agents like trehalose (5%) has proven effective for bovine kappa-casein stability .

  • Degradation monitoring: Regular SDS-PAGE analysis to detect proteolytic degradation during storage.

  • Activity assays: Develop functional assays to confirm biological activity retention during storage.

Expected stability: Properly formulated and stored recombinant kappa-casein should maintain >95% integrity within the established expiration period .

What strategies effectively address inclusion body formation during recombinant Rupicapra rupicapra Kappa-casein expression?

When inclusion bodies form despite optimization efforts, these approaches can recover functional protein:

  • Prevention strategies:

    • Lower induction temperature (16-20°C)

    • Reduce inducer concentration

    • Co-express molecular chaperones

    • Use solubility-enhancing fusion partners (SUMO, thioredoxin)

  • Recovery protocols:

    • Isolate inclusion bodies through differential centrifugation

    • Solubilize using chaotropic agents (6-8M urea or 4-6M guanidine hydrochloride)

    • Implement stepwise dialysis for refolding

    • Add oxidizing/reducing agents to facilitate correct disulfide bond formation

  • Refolding optimization:

    • Screen multiple refolding buffers using factorial design

    • Consider pulsatile dilution techniques

    • Monitor refolding efficiency using activity assays

How can genetic variation in the Rupicapra rupicapra CSN3 gene be correlated with functional protein differences?

Investigating structure-function relationships requires integrating genetic and biochemical approaches:

  • Identify polymorphic regions within the CSN3 gene through population genetics studies

  • Express recombinant variants representing major haplotypes

  • Characterize biochemical and functional differences between variants

  • Analyze how specific amino acid substitutions affect:

    • Protein stability

    • Glycosylation patterns

    • Chymosin cleavage efficiency

    • Micelle stabilization properties

Bovine studies demonstrate that promoter polymorphisms at positions -514, -426, and -384 may influence transcriptional regulation through altered transcription factor binding . Similar analyses can be applied to Rupicapra rupicapra to correlate genetic variation with expression levels and protein functionality.

What approaches reveal differences in post-translational modifications between native and recombinant Rupicapra rupicapra Kappa-casein?

Post-translational modifications significantly impact kappa-casein function. Studies comparing recombinant human CMP with native bovine CMP revealed differences in glycosylation patterns . To investigate these differences in Rupicapra rupicapra:

  • Glycosylation analysis:

    • Glycoprotein-specific staining following SDS-PAGE

    • Lectin affinity chromatography to capture glycosylated variants

    • Mass spectrometry to characterize glycan structures

    • Enzymatic deglycosylation to assess impact on function

  • Phosphorylation studies:

    • Phosphoprotein staining techniques

    • LC-MS/MS analysis to identify phosphorylation sites

    • Site-directed mutagenesis to evaluate functional significance

  • Comparative analysis:

    • Direct comparison between native (milk-derived) and recombinant forms

    • Functional assays to determine biological significance of modification differences

How should researchers design experiments to compare promoter activity between Rupicapra rupicapra and other ruminant species?

To accurately compare promoter function across species:

  • Isolation and cloning:

    • Isolate promoter regions from multiple species including Rupicapra rupicapra, Bos taurus, and other ruminants

    • Clone into reporter constructs (luciferase or GFP)

  • Transfection studies:

    • Test activity in relevant cell lines (mammary epithelial cells preferable)

    • Measure reporter activity under various conditions (hormonal stimulation, etc.)

  • Deletion and mutation analysis:

    • Create progressive deletions to identify critical regulatory regions

    • Introduce site-specific mutations at putative transcription factor binding sites

    • Focus on regions analogous to the -514, -426, and -384 positions identified in bovine studies

  • Transcription factor binding studies:

    • Electrophoretic mobility shift assays (EMSA)

    • Chromatin immunoprecipitation (ChIP)

    • DNA-protein interaction analysis through footprinting

What are effective solutions for resolving protein aggregation during Rupicapra rupicapra Kappa-casein purification?

Protein aggregation can significantly reduce yields of functional protein. Implement these strategies:

  • Prevention during expression:

    • Lower growth temperature to 16-20°C

    • Reduce inducer concentration

    • Co-express molecular chaperones

  • Solubilization approaches:

    • Add mild detergents (0.05-0.1% Tween-20 or Triton X-100)

    • Include stabilizing agents (trehalose, glycerol, arginine)

    • Optimize buffer pH and ionic strength

  • Chromatographic considerations:

    • Include 5-10% glycerol in all buffers

    • Add reducing agents to prevent disulfide-mediated aggregation

    • Consider size exclusion chromatography as a final polishing step

  • Storage conditions:

    • Store at moderate protein concentrations (0.1-1.0 mg/mL)

    • Avoid freeze-thaw cycles by preparing single-use aliquots

    • Consider lyophilization with appropriate cryoprotectants

How can researchers mitigate endotoxin contamination in recombinant Rupicapra rupicapra Kappa-casein preparations?

Endotoxin contamination is a critical concern, particularly for functional studies. Commercial bovine kappa-casein preparations maintain endotoxin levels below 1.0 EU per 1μg . To achieve similar purity:

  • Preventive measures:

    • Use endotoxin-free reagents and labware

    • Implement dedicated equipment for cell culture and protein purification

    • Consider expression in gram-positive hosts or eukaryotic systems

  • Removal techniques:

    • Two-phase extraction using Triton X-114

    • Polymyxin B affinity chromatography

    • Anion exchange chromatography at high salt concentrations

    • Commercial endotoxin removal kits

  • Validation methods:

    • Limulus Amebocyte Lysate (LAL) assay for endotoxin quantification

    • Conduct parallel control experiments to verify removal efficiency

What experimental design approaches help resolve contradictory results in Rupicapra rupicapra Kappa-casein functional studies?

When contradictory results arise, implement these systematic troubleshooting approaches:

  • Rigorous experimental design:

    • Follow the five criteria for good experimental design: unbiased comparisons, high precision, wide applicability, simplicity, and calculated uncertainty

    • Use factorial designs to systematically evaluate variables and their interactions

  • Standardization procedures:

    • Establish standardized protocols for expression, purification, and functional assays

    • Use reference standards (commercially available bovine kappa-casein)

    • Document all experimental conditions comprehensively

  • Statistical validation:

    • Ensure sufficient biological and technical replicates

    • Apply appropriate statistical tests to determine significance

    • Report effect sizes and confidence intervals

  • Cross-validation approaches:

    • Employ multiple complementary analytical techniques

    • Verify key findings using alternative methods

    • Consider inter-laboratory validation for critical results

How can comparative genomics inform evolutionary studies of Rupicapra rupicapra Kappa-casein?

Evolutionary analysis provides insights into functional conservation and adaptation:

  • Phylogenetic analysis:

    • Compare CSN3 sequences across ruminants, with particular focus on alpine species

    • Analyze selection pressures on different domains

    • Examine evolutionary relationships between haplotype structures in different species

  • Promoter evolution:

    • Compare transcriptional regulatory elements across species

    • Analyze conservation of the key polymorphic sites (-514, -426, -384) identified in bovine studies

    • Correlate promoter structure with expression patterns and ecological adaptation

  • Functional domain evolution:

    • Compare rates of evolution in different protein domains

    • Analyze glycosylation site conservation

    • Investigate species-specific adaptations in functional regions

What novel purification approaches might improve yield and purity of recombinant Rupicapra rupicapra Kappa-casein?

Innovative purification strategies to consider:

  • Alternative affinity tags:

    • Evaluate performance of various fusion tags beyond the standard His and GST tags

    • Consider self-cleaving intein tags for tag-free protein production

    • Explore species-specific affinity ligands based on natural binding partners

  • Membrane-based techniques:

    • High-performance tangential flow filtration

    • Charged ultrafiltration membranes for selective separation

    • Expanded bed adsorption for direct capture from crude lysates

  • Non-chromatographic methods:

    • Aqueous two-phase extraction

    • Selective precipitation techniques

    • Controlled aggregation/disaggregation approaches

  • Continuous processing:

    • Simulated moving bed chromatography

    • Sequential multi-column chromatography

    • Integrated expression-purification systems

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.